219 related articles for article (PubMed ID: 28801361)
1. One level up: abnormal proteolytic regulation of IGF activity plays a role in human pathophysiology.
Argente J; Chowen JA; Pérez-Jurado LA; Frystyk J; Oxvig C
EMBO Mol Med; 2017 Oct; 9(10):1338-1345. PubMed ID: 28801361
[TBL] [Abstract][Full Text] [Related]
2. Novel Modulators of the Growth Hormone - Insulin-Like Growth Factor Axis: Pregnancy-Associated Plasma Protein-A2 and Stanniocalcin-2.
Fujimoto M; Hwa V; Dauber A
J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):1-8. PubMed ID: 29280739
[TBL] [Abstract][Full Text] [Related]
3. Stanniocalcin-1 Potently Inhibits the Proteolytic Activity of the Metalloproteinase Pregnancy-associated Plasma Protein-A.
Kløverpris S; Mikkelsen JH; Pedersen JH; Jepsen MR; Laursen LS; Petersen SV; Oxvig C
J Biol Chem; 2015 Sep; 290(36):21915-24. PubMed ID: 26195635
[TBL] [Abstract][Full Text] [Related]
4. Pappalysins and Stanniocalcins and Their Relationship With the Peripheral IGF Axis in Newborns and During Development.
Martín-Rivada Á; Guerra-Cantera S; Campillo-Calatayud A; Andrés-Esteban EM; Sánchez Holgado M; Martos-Moreno GÁ; Pozo J; Güemes M; Soriano-Guillén L; Pellicer A; Oxvig C; Frystyk J; Chowen JA; Barrios V; Argente J
J Clin Endocrinol Metab; 2022 Sep; 107(10):2912-2924. PubMed ID: 35902207
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy-associated plasma proteins and Stanniocalcin-2 - Novel players controlling IGF-I physiology.
Frystyk J; Teran E; Gude MF; Bjerre M; Hjortebjerg R
Growth Horm IGF Res; 2020; 53-54():101330. PubMed ID: 32693362
[TBL] [Abstract][Full Text] [Related]
6. The proteolytic activity of pregnancy-associated plasma protein-A is potentially regulated by stanniocalcin-1 and -2 during human ovarian follicle development.
Jepsen MR; Kløverpris S; Bøtkjær JA; Wissing ML; Andersen CY; Oxvig C
Hum Reprod; 2016 Apr; 31(4):866-74. PubMed ID: 26874357
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy-Associated Plasma Protein (PAPP)-A2 in Physiology and Disease.
Barrios V; Chowen JA; Martín-Rivada Á; Guerra-Cantera S; Pozo J; Yakar S; Rosenfeld RG; Pérez-Jurado LA; Suárez J; Argente J
Cells; 2021 Dec; 10(12):. PubMed ID: 34944082
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy associated plasma protein-A2 (PAPP-A2) and stanniocalcin-2 (STC2) but not PAPP-A are associated with circulating total IGF-1 in a human adult population.
Nimptsch K; Aydin EE; Chavarria RFR; Janke J; Poy MN; Oxvig C; Steinbrecher A; Pischon T
Sci Rep; 2024 Jan; 14(1):1770. PubMed ID: 38245583
[TBL] [Abstract][Full Text] [Related]
9. Depot-specific and GH-dependent regulation of IGF binding protein-4, pregnancy-associated plasma protein-A, and stanniocalcin-2 in murine adipose tissue.
Hjortebjerg R; Berryman DE; Comisford R; List EO; Oxvig C; Bjerre M; Frystyk J; Kopchick JJ
Growth Horm IGF Res; 2018 Apr; 39():54-61. PubMed ID: 29398370
[TBL] [Abstract][Full Text] [Related]
10. Stanniocalcin-2 inhibits mammalian growth by proteolytic inhibition of the insulin-like growth factor axis.
Jepsen MR; Kløverpris S; Mikkelsen JH; Pedersen JH; Füchtbauer EM; Laursen LS; Oxvig C
J Biol Chem; 2015 Feb; 290(6):3430-9. PubMed ID: 25533459
[TBL] [Abstract][Full Text] [Related]
11. The IGF-PAPP-A-Stanniocalcin Axis in Serum and Ascites Associates with Prognosis in Patients with Ovarian Cancer.
Hjortebjerg R; Høgdall C; Hansen KH; Høgdall E; Frystyk J
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396692
[TBL] [Abstract][Full Text] [Related]
12. Disorders caused by genetic defects associated with GH-dependent genes: PAPPA2 defects.
Fujimoto M; Andrew M; Dauber A
Mol Cell Endocrinol; 2020 Dec; 518():110967. PubMed ID: 32739295
[TBL] [Abstract][Full Text] [Related]
13. A common variant of the pregnancy-associated plasma protein-A (PAPPA) gene encodes a protein with reduced proteolytic activity towards IGF-binding proteins.
Bøtkjær JA; Noer PR; Oxvig C; Yding Andersen C
Sci Rep; 2019 Sep; 9(1):13231. PubMed ID: 31519945
[TBL] [Abstract][Full Text] [Related]
14. Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability.
Dauber A; Muñoz-Calvo MT; Barrios V; Domené HM; Kloverpris S; Serra-Juhé C; Desikan V; Pozo J; Muzumdar R; Martos-Moreno GÁ; Hawkins F; Jasper HG; Conover CA; Frystyk J; Yakar S; Hwa V; Chowen JA; Oxvig C; Rosenfeld RG; Pérez-Jurado LA; Argente J
EMBO Mol Med; 2016 Apr; 8(4):363-74. PubMed ID: 26902202
[TBL] [Abstract][Full Text] [Related]
15. Placental proteases PAPP-A and PAPP-A2, the binding proteins they cleave (IGFBP-4 and -5), and IGF-I and IGF-II: Levels in umbilical cord blood and associations with birth weight and length.
DiPrisco B; Kumar A; Kalra B; Savjani GV; Michael Z; Farr O; Papathanasiou AE; Christou H; Mantzoros C
Metabolism; 2019 Nov; 100():153959. PubMed ID: 31401027
[TBL] [Abstract][Full Text] [Related]
16. Increased activity of the metalloproteinase PAPP-A promotes diabetes-induced glomerular hypertrophy.
Jepsen MR; Østergaard JA; Conover CA; Wogensen L; Birn H; Krag SP; Fenton RA; Oxvig C
Metabolism; 2022 Jul; 132():155218. PubMed ID: 35588861
[TBL] [Abstract][Full Text] [Related]
17. Low IGF-I Bioavailability Impairs Growth and Glucose Metabolism in a Mouse Model of Human PAPPA2 p.Ala1033Val Mutation.
Fujimoto M; Andrew M; Liao L; Zhang D; Yildirim G; Sluss P; Kalra B; Kumar A; Yakar S; Hwa V; Dauber A
Endocrinology; 2019 Jun; 160(6):1363-1376. PubMed ID: 30977789
[TBL] [Abstract][Full Text] [Related]
18. PAPP-A2 a new key regulator of growth.
Banaszak-Ziemska M; Niedziela M
Endokrynol Pol; 2017; 68(6):682-691. PubMed ID: 29238946
[TBL] [Abstract][Full Text] [Related]
19. The Stanniocalcin-PAPP-A-IGFBP-IGF Axis.
Oxvig C; Conover CA
J Clin Endocrinol Metab; 2023 Jun; 108(7):1624-1633. PubMed ID: 36718521
[TBL] [Abstract][Full Text] [Related]
20. Abnormal expression of Pappa2 gene may indirectly affect mouse hip development through the IGF signaling pathway.
Chen Y; Li L; Wang E; Zhang L; Zhao Q
Endocrine; 2019 Aug; 65(2):440-450. PubMed ID: 31168749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
